Q2 results on Oct 26, 2016
IIFL Holdings Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 26, 2016, inter alia, to consider and approve the following;- Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2016 (Q2);Further, pursuant to the Company's Code of Conduct for Prevention of Insider Trading and Disclosure Practices, the Trading Window shall remain... Shareholding for the Period Ended September 30, 2016
IIFL Holdings Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here IIFL gets nod to demerge 5Paisa Digital Undertaking
IIFL Holdings has received nod from its board to demerge '5Paisa Digital Undertaking' from IIFL Holdings Ltd (IIFL) into its fully owned subsidiary 5Paisa Capital Ltd (5Paisa). "The board of directors of the company at their meeting held today... Intimation of Schedule of Investor Road Shows
IIFL Holdings Ltd has informed BSE regarding "Intimation of Schedule of Investor Road Shows". Outcome of Board Meeting
IIFL Holdings Ltd has informed BSE that the Board of Directors of the Company at their meeting held on September 30, 2016 considered and approved the proposed demerger of '5Paisa Digital Undertaking' from IIFL Holdings Limited ("IIFL") into 5Paisa Capital Limited ("5paisa"), a 100% subsidiary of IIFL engaged in distribution of financial services and broking, as follows:... Update on investment by CDC Group plc in India Infoline Finance Ltd, the NBFC arm of IIFL Holdings Ltd
IIFL Holdings Ltd has informed BSE regarding "Update on investment by CDC Group plc in India Infoline Finance Ltd, the NBFC arm of IIFL Holdings Ltd.". 3 stocks to invest in long term: IIFL
We are recommending some long-term stocks which have outperformed the market in the recent past and we continue to be bullish on them. Allotment of Equity Shares upon exercise of ESOPs
IIFL Holdings Ltd has informed BSE that the Nomination and Remuneration Committee of the Board of Directors of the Company by way of circular resolution(s) allotted 2,40,500 equity shares to the employees of the Company/ Subsidiaries upon exercise of stock options under Employee Stock Option Schemes.Upon allotment, the equity base of the Company stand increased from equity shares 31,68,55,353 to 31,70,95,853 equity shares of Rs. 2/- each. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Bank of Nova Scotia has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 Taro drug pricing probe may widen to other generic drug makers
Research by IIFL shows several generic drug companies, including a few top Indian generic drug makers, effected steep price increases within a short time frame.